A Path Analysis Modeling of the Interaction of AXII and/or AXIIR with the Changes in Cytokines and Myeloma Bone Disease

Study on Bone Health in a Type of Blood Cancer

Recruiting
18 years - 90 years
All
Phase N/A
1 Location

Brief description of study.

The purpose of this research study is to learn if substances that cause bone destruction are increased in the blood or bone marrow.

Detailed description of study

The purpose of this research study is to learn if substances that cause bone destruction are increased in the blood or bone marrow.

Participants may be paid for their participation.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: Myeloma Bone Disease,Multiple Myeloma,Myeloma,Cancer,Oncology
  • Age: 18 years - 90 years
  • Gender: All

Inclusion Criteria
Diagnosed with multiple myeloma


Exclusion Criteria
Currently pregnant
Are allergic to xylocaine
Currently enrolled in another research study

Updated on 19 Feb 2024. Study ID: 1204008459 (IUCRO-0373)

This study investigates whether certain substances that lead to bone destruction are increased in the blood or bone marrow of individuals with multiple myeloma. Multiple myeloma is a type of cancer that affects plasma cells, which are a part of the immune system.

Participants will undergo blood tests and bone marrow examinations to measure the levels of these substances. These procedures help researchers understand the relationship between these substances and bone health.

  • Who can participate: Adults with a diagnosis of multiple myeloma, who are not pregnant, not allergic to xylocaine, and not participating in another study, are eligible.
  • Study details: Participants will provide blood samples and may have bone marrow examinations. A placebo will not be used.

Find a site

Message sent successfully.
We have submitted the information you provided to the research team at the location you chose. For your records, we have sent a copy of the message to your email address.
If you would like to be informed of other studies that may be of interest to you, you may sign up for Patient Notification Service.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Preferred way of contact label
Race
Ethnicity
Other language

Default Content Message Here